Skip to content

Evaluation of the Ketogenic Potential of Different Diet Supplements

Stimulating the Ketogenesis by Using Nutritional Supplements

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02693106
Enrollment
13
Registered
2016-02-26
Start date
2013-07-31
Completion date
2015-06-30
Last updated
2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Keywords

Ketones, Butyrate, Leucine, Octanoate, Carnitine, Medium Chain Triglycerides

Brief summary

Evaluate the capacity of different dietary supplements to increase ketone production in healthy adults.

Detailed description

The aim of this study is to evaluate the capacity of different dietary supplements to increase ketone production in healthy adults. Each supplement (leucine, butyrate, octanoate, carnitine or butter fraction rich in MCT) is evaluated for a period of 4-hour during which multiple blood samples are taken in order to measure ketone production.

Interventions

DIETARY_SUPPLEMENTControl

Visit corresponding to a standardize breakfast taken alone (control visit) followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENTLeucine

Visit corresponding to a standardize breakfast with 5 g of leucine followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENTButyrate -

Visit corresponding to a standardize breakfast with 3.6 g of butyrate followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENTButyrate +

Visit corresponding to a standardize breakfast with 7.2 g of butyrate followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENTOctanoate -

Visit corresponding to a standardize breakfast with 5 g of octanoate followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENTOctanoate +

Visit corresponding to a standardize breakfast with 10 g of octanoate followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENTCarnitine

Visit corresponding to a standardize breakfast with 1.95 g of carnitine followed by a period of 4-hour with multiple blood sampling.

DIETARY_SUPPLEMENTButter fraction

Visit corresponding to a standardize breakfast with 65 g of butter fraction followed by a period of 4-hour with multiple blood sampling.

Sponsors

Université de Sherbrooke
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults aged of 18 years old or older. * Non-smoking.

Exclusion criteria

* Diabetes or prediabetes * Uncontrolled hypertension * Uncontrolled thyroid function * Taking medication that will affect lipid/glucose metabolism * Severe infection or inflammation * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Concentration of Total Plasma Ketones4 hoursDifference from Time 0 in Total ketones = acetoacetate (umol/L) + beta-hydroxybutyrate (umol/L) Time 0 is when the participants arrived, after a 12 hours fast, i.e. before the breakfast. Plasma was collected every 30 minutes for 4 hours immediately following breakfast (where supplements were taken). Results are the mean of plasma ketones measured every 30 minutes ( i.e. total of 9 plasma samples) for the 4 hour period. For each time point, the difference form time 0 has been made. So this is the mean of the difference from time 0 in total ketones. Data were not collected for the 'Intervention 8: 65 g of butter fraction rich in MCT' supplement.

Countries

Canada

Participant flow

Participants by arm

ArmCount
Ketogenic Potential
Each participant has to go through a total of 8 visits, each visit corresponding to a standardize breakfast taken alone (control visit) or with one of the dietary supplements evaluated followed by a period of 4-hour with multiple blood sampling. Intervention 1: Control; no supplement Intervention 2: 5 g of leucine Intervention 3: 3.6 g of butyrate Intervention 4: 7.2 g of butyrate Intervention 5: 5 g of octanoate Intervention 6: 10 g of octanoate Intervention 7: 1.95 g of carnitine Intervention 8: 65 g of butter fraction rich in MCT
13
Total13

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyNo time3

Baseline characteristics

CharacteristicKetogenic Potential
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
13 Participants
Age, Continuous34 years
STANDARD_DEVIATION 4
Region of Enrollment
Canada
13 Participants
Sex: Female, Male
Female
10 Participants
Sex: Female, Male
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —— / —— / —— / —
other
Total, other adverse events
0 / 100 / 102 / 103 / 102 / 103 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 100 / 100 / 100 / 100 / 100 / 10

Outcome results

Primary

Concentration of Total Plasma Ketones

Difference from Time 0 in Total ketones = acetoacetate (umol/L) + beta-hydroxybutyrate (umol/L) Time 0 is when the participants arrived, after a 12 hours fast, i.e. before the breakfast. Plasma was collected every 30 minutes for 4 hours immediately following breakfast (where supplements were taken). Results are the mean of plasma ketones measured every 30 minutes ( i.e. total of 9 plasma samples) for the 4 hour period. For each time point, the difference form time 0 has been made. So this is the mean of the difference from time 0 in total ketones. Data were not collected for the 'Intervention 8: 65 g of butter fraction rich in MCT' supplement.

Time frame: 4 hours

ArmMeasureGroupValue (MEAN)Dispersion
Ketogenic PotentialConcentration of Total Plasma KetonesCTL-18.2 µmol/LStandard Error 20
Ketogenic PotentialConcentration of Total Plasma KetonesLeucine23 µmol/LStandard Error 25
Ketogenic PotentialConcentration of Total Plasma KetonesButyrate 3.6g12.2 µmol/LStandard Error 44.4
Ketogenic PotentialConcentration of Total Plasma KetonesButyrate 7.2g68.5 µmol/LStandard Error 35.9
Ketogenic PotentialConcentration of Total Plasma KetonesOctanoate 5g-3.4 µmol/LStandard Error 32.8
Ketogenic PotentialConcentration of Total Plasma KetonesOctanoate 10 g39.7 µmol/LStandard Error 34
Ketogenic PotentialConcentration of Total Plasma KetonesCarnitine-30 µmol/LStandard Error 21.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026